Minerva Neurosciences reported $44.84M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Adma Biologics ADMA:US USD 224.1M 1.32M
ALKERMES ALKS:US USD 1.05B 7.81M
AstraZeneca AZN:LN USD 20.22B 693M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Eli Lilly And LLY:US USD 17.64B 524.7M
Esperion Therapeutics ESPR:US USD 261.78M 9.31M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Marinus Pharmaceuticals MRNS:US USD 177.01M 75.91M
Minerva Neurosciences NERV:US USD 44.84M 5.2M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NOVN:VX USD 36.95B 1.19B
Novavax NVAX:US USD 1.76B 376.04M
Takeda 4502:JP JPY 2.75T 196.1B
Vanda Pharmaceuticals VNDA:US USD 507.11M 10.21M